Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Latest Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Positive top line results from Shire's LDX phase III study on ADHD

Shire plc, the global specialty biopharmaceutical company, today presented positive top line results of the first European phase III study of once-daily lisdexamfetamine dimesylate (LDX) in children and adolescents aged 6 to 17 years with Attention-Deficit/Hyperactivity Disorder.

22 Oct 2011

Research points to ineffective and incomplete drug education as factor in heroin initiation

Researchers found Chicago area suburban heroin users have little knowledge about the drug and its effects when they first use it, and they often substitute heroin after becoming addicted to prescription pain medications.

19 Oct 2011

New series on child abuse on UBM Medica's Pediatrics Consultant Live

UBM Medica's Pediatrics Consultant Live has a new series called "Child Abuse–or Mimic?" which helps clinicians distinguish cases of child abuse from pediatric disease or mere accidents.

15 Oct 2011

Watson confirms patent challenge of generic Daytrana

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Methylphenidate Transdermal System, 10 mg/9 hrs, 15 mg/9 hrs, 20 mg/9 hrs, and 30 mg/9 hrs.

15 Oct 2011

Stimulant prescription use for ADHD has increased steadily from 1996-2008

The prescribed use of stimulant medications to treat attention deficit hyperactivity disorder (ADHD) rose slowly but steadily from 1996 to 2008, according to a study conducted by the National Institutes of Health (NIH) and the Agency for Healthcare Research and Quality (AHRQ). The study was published online ahead of print September 28, 2011, in the American Journal of Psychiatry.

28 Sep 2011

Methylphenidate drug may induce arousal from general anesthesia

Administration of the commonly used stimulant drug methylphenidate (Ritalin) was able to speed recovery from general anesthesia in an animal study conducted at Massachusetts General Hospital.

22 Sep 2011

ADHD symptoms might affect adaptive abilities, quality of life for children with ASD

Research supported by the Autism Speaks Autism Treatment Network (ATN), demonstrating that symptoms of attention deficit and hyperactivity worsen quality of life for individuals with autism spectrum disorders (ASD), was presented today at the Society for Developmental & Behavioral Pediatrics Annual Meeting in San Antonio, Texas.

20 Sep 2011

Exposure to green play settings could help treat ADHD in children

A study of more than 400 children diagnosed with Attention Deficit Hyperactivity Disorder has found a link between the children's routine play settings and the severity of their symptoms, researchers report.

16 Sep 2011

CHK Nutrition, NeuroResearch Clinics sign consent to halt sale of unapproved amino-acid products

The U.S. Food and Drug Administration announced that two Minnesota companies have agreed to halt distribution of amino-acid products marketed to treat a number of diseases, until requirements of the Federal Food, Drug, and Cosmetic Act are met.

15 Sep 2011

Children with more ADHD symptoms twice as likely to get hurt

Injury kills more 11-year-olds in the United States than all other causes combined, and a new study from University of Alabama at Birmingham reveals ADHD almost doubles the risk of serious injury among this age group.

14 Sep 2011

Top-line results from Teva-Alcobra MG01CI Phase II trial for ADHD

Teva Pharmaceutical Industries Ltd. and Alcobra Ltd. announced today top-line results from a six week, randomized, placebo-controlled, Phase II multi-center study designed to assess the safety and efficacy of MG01CI in adults with attention deficit hyperactivity disorder (ADHD).

7 Sep 2011

Study sheds new light on the state of Europe's mental and neurological health

A major landmark study released today by the European College of Neuropsychopharmacology (ECNP) sheds new light on the state of Europe's mental and neurological health.

5 Sep 2011

Novel analysis of MRI scans reveals distinct features of autistic brain

Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital have used a novel method for analyzing brain-scan data to distinguish children with autism from typically developing children.

3 Sep 2011

New research: Inattention associated with educational failure

New research from the University of Montreal shows that inattention, rather than hyperactivity, is the most important indicator when it comes to finishing a high school education.

29 Aug 2011

Clay modelling could help disturbed teenagers deal with mental health problems

Researchers at The University of Nottingham are to investigate whether the therapeutic effects of clay modelling could help disturbed teenagers deal with their feelings of anger, anxiety and depression.

24 Aug 2011

Disability benefits squeezing social security as politics dominates deficit talk

It's August, Congress and the president are on vacation. Nonetheless, talk on the Sunday morning programs looked ahead to the future deficit negotiations by the "super committee" and the president's upcoming economics speech.

22 Aug 2011

More kids being diagnosed with ADHD

A new study revealed that number of children diagnosed with Attention Deficit Hyperactivity disorder or ADHD has risen sharply over the last decade.

18 Aug 2011

First Edition: August 18, 2011

"The SSI program for children is rapidly expanding, with the biggest increase among kids with mental, behavioral and learning disorders, including ADHD, speech delays, autism, and bipolar disorder. But as it pulls in children like Hulston, the program is sparking criticism in Congress.

18 Aug 2011

NIH study in mice shows potential new target for treatment of ADHD

A study using mice provides insight into how a specific receptor subtype in the brain could play a role in increasing a person's risk for attention-deficit hyperactivity disorder.

17 Aug 2011

Scientists identify new therapeutic target for ADHD, other neuropsychiatric disorders

A biochemical pathway long associated with diarrhea and intestinal function may provide a new therapeutic target for treating ADHD other neuropsychiatric disorders, according to a team of scientists from China and the United States reporting Aug. 11 in Science.

12 Aug 2011